Chromocell Therapeutics Corp (CHRO)
1.99
-0.18
(-8.29%)
USD |
NYAM |
May 15, 15:53
Chromocell Therapeutics Shareholders Equity (Quarterly): -5.905M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -5.905M |
| June 30, 2023 | -4.901M |
| March 31, 2023 | -4.401M |
| Date | Value |
|---|---|
| December 31, 2022 | -3.706M |
| September 30, 2022 | 41.28M |
| December 31, 2021 | -3.680M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.905M
Minimum
Sep 2023
41.28M
Maximum
Sep 2022
3.115M
Average
-4.054M
Median
Shareholders Equity (Quarterly) Benchmarks
| iBio Inc | 9.197M |
| Lixte Biotechnology Holdings Inc | 3.995M |
| PDS Biotechnology Corp | 26.13M |
| Syros Pharmaceuticals Inc | 16.66M |
| Nutriband Inc | 6.438M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.0228M |
| Total Liabilities (Quarterly) | 5.927M |